Login / Signup

Clinical significance of lung cross-sectional area measured by computed tomography in chronic thromboembolic pulmonary hypertension: The correlation with pulmonary hemodynamics and the limitations.

Ayaka KuriyamaHajime KasaiToshihiko SugiuraJun NagataAkira NaitoAyumi SekineAyako ShigetaSeiichiro SakaoKeiichi IshidaGoro MatsumiyaNobuhiro TanabeTakuji Suzuki
Published in: Pulmonary circulation (2023)
The percentage cross-sectional area of the lung under five (%CSA <5 ) is the percentage of pulmonary vessels with <5 mm 2 area relative to the total lung area on computed tomography (CT). The extent that %CSA <5 is related to pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) is unclear, as is the effect of pulmonary endarterectomy (PEA) on %CSA <5 . Therefore, we aimed to evaluate the clinical significance of %CSA <5 in patients with CTEPH. We studied 98 patients (64 females, mean age 62.5 ± 11.9 years), who underwent CT with %CSA <5 measurement and right heart catheterization (RHC). Patients were classified into groups based on eligibility for PEA. We compared the %CSA <5 with pulmonary hemodynamics measured by RHC in various groups. In 38 patients who underwent PEA, the relationship between %CSA <5 and pulmonary hemodynamics was also evaluated before and after PEA. Significant correlations between %CSA <5 and pulmonary vascular resistance, and compliance, and pulmonary artery pulse pressure were observed in all patients. Pulmonary hemodynamics in the patients who underwent or were eligible for PEA showed a significant correlation with %CSA <5 . Additionally, %CSA <5 was significantly lower in the postoperative than in the preoperative group. There was no correlation between changes in %CSA <5 and pulmonary hemodynamics before and after PEA. Furthermore, %CSA <5 did not correlate significantly with prognosis. %CSA <5 may reflect pulmonary hemodynamics in CTEPH with central thrombosis. Furthermore, %CSA <5 was reduced by PEA postoperatively. However, %CSA <5 is not a prognostic indicator, its clinical usefulness in CTEPH patients is limited, and further validation is required.
Keyphrases